Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
PTGX
|
Dinesh V Ph D Patel
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,648 Reduced 0.91% |
$112,853
$24.28 p/Share
|
Feb 28
2022 |
PTGX
|
Suneel Gupta
Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 649 Reduced 0.84% |
$15,758
$24.28 p/Share
|
Feb 28
2022 |
AERI
|
Benjamin F Mcgraw Iii
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 10,324 Reduced 22.41% |
$85,689
$8.3 p/Share
|
Feb 28
2022 |
HVT
|
Steven G Burdette
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 3,024 Added 18.8% |
-
|
Feb 28
2022 |
HVT
|
Steven G Burdette
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,468 Reduced 11.24% |
$41,706
$28.41 p/Share
|
Feb 28
2022 |
HVT
|
J Edward Clary
Executive VP & CIO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,615 Added 7.91% |
-
|
Feb 28
2022 |
HVT
|
J Edward Clary
Executive VP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,325 Reduced 4.35% |
$37,643
$28.41 p/Share
|
Feb 28
2022 |
HVT
|
Helen Berry Bautista
Senior Vice President, Mktg |
BUY
Exercise of conversion of derivative security
|
Direct | 566 Added 21.39% |
-
|
Feb 28
2022 |
HVT
|
Helen Berry Bautista
Senior Vice President, Mktg |
SELL
Payment of exercise price or tax liability
|
Direct | 201 Reduced 9.66% |
$5,710
$28.41 p/Share
|
Feb 28
2022 |
HVT
|
Kelly Allen Fladger
SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,491 Added 25.54% |
-
|
Feb 28
2022 |
HVT
|
Kelly Allen Fladger
SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 528 Reduced 12.15% |
$15,000
$28.41 p/Share
|
Feb 28
2022 |
HVT
|
John Linwood Gill
Executive V.P., Merchandising |
BUY
Exercise of conversion of derivative security
|
Direct | 1,656 Added 10.88% |
-
|
Feb 28
2022 |
HVT
|
John Linwood Gill
Executive V.P., Merchandising |
SELL
Payment of exercise price or tax liability
|
Direct | 802 Reduced 5.91% |
$22,785
$28.41 p/Share
|
Feb 28
2022 |
HVT
|
Richard B Hare
EVP, CFO & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 3,024 Added 18.17% |
-
|
Feb 28
2022 |
HVT
|
Richard B Hare
EVP, CFO & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 1,532 Reduced 11.25% |
$43,524
$28.41 p/Share
|
Feb 28
2022 |
HVT
|
Rawson Haverty Jr
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,656 Added 9.62% |
-
|
Feb 28
2022 |
HVT
|
Rawson Haverty Jr
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 851 Reduced 5.47% |
$24,177
$28.41 p/Share
|
Feb 28
2022 |
HVT
|
Jenny H Parker
Sr. VP, Finance & Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct | 1,656 Added 6.57% |
-
|
Feb 28
2022 |
HVT
|
Jenny H Parker
Sr. VP, Finance & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct | 806 Reduced 3.42% |
$22,898
$28.41 p/Share
|
Feb 28
2022 |
HVT
|
Clarence H Smith
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 8,477 Added 20.17% |
-
|
Feb 28
2022 |
HVT
|
Clarence H Smith
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 6,094 Reduced 18.17% |
$173,131
$28.41 p/Share
|
Feb 28
2022 |
HVT
|
Janet E Taylor
Sr. VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 1,656 Added 3.39% |
-
|
Feb 28
2022 |
HVT
|
Janet E Taylor
Sr. VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 839 Reduced 1.78% |
$23,836
$28.41 p/Share
|
Feb 28
2022 |
ALT
|
Matthew Scott Harris
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 30,000 Added 41.93% |
$57,600
$1.92 p/Share
|
Feb 28
2022 |
ALT
|
Matthew Scott Harris
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 72.21% |
$225,600
$7.52 p/Share
|
Feb 28
2022 |
BBBY
|
Jeff Kirwan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,705 Added 9.97% |
$48,758
$13.16 p/Share
|
Feb 28
2022 |
BBBY
|
Ann Yerger
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,895 Added 9.43% |
$51,258
$13.16 p/Share
|
Feb 28
2022 |
BBBY
|
Harriet Edelman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,420 Added 5.09% |
$45,007
$13.16 p/Share
|
Feb 28
2022 |
KOP
|
Joseph P Dowd
VP, Zero Harm |
SELL
Open market or private sale
|
Direct | 1,749 Reduced 5.22% |
$50,284
$28.75 p/Share
|
Feb 28
2022 |
SKLZ
|
Harry Sloan
Director |
BUY
Open market or private purchase
|
Direct | 94,880 Added 33.14% |
$294,128
$3.1 p/Share
|
Feb 28
2022 |
SRDX
|
Susan E Knight |
BUY
Exercise of conversion of derivative security
|
Direct | 4,366 Added 11.22% |
$88,106
$20.18 p/Share
|
Feb 28
2022 |
SRDX
|
Susan E Knight |
SELL
Open market or private sale
|
Direct | 4,366 Reduced 12.63% |
$196,339
$44.97 p/Share
|
Feb 28
2022 |
BBSI
|
Gerald Blotz
Executive VP & COO |
BUY
Grant, award, or other acquisition
|
Direct | 1,796 Added 4.22% |
-
|
Feb 28
2022 |
BBSI
|
Gary Kramer
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 1,796 Added 4.99% |
-
|
Feb 28
2022 |
HYLN
|
Greg Standley
Chief Accounting Officer. |
BUY
Grant, award, or other acquisition
|
Direct | 18,634 Added 28.55% |
-
|
Feb 28
2022 |
PACK
|
Omar Asali
CEO & Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 105,000 Added 4.71% |
-
|
Feb 28
2022 |
PACK
|
Antonio Grassotti
Managing Director, APAC |
BUY
Grant, award, or other acquisition
|
Direct | 21,500 Added 31.19% |
-
|
Feb 28
2022 |
PACK
|
Eric Laurensse
Managing Director, Europe |
BUY
Grant, award, or other acquisition
|
Direct | 40,001 Added 34.54% |
-
|
Feb 28
2022 |
PACK
|
Michael S. Gliedman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 20.84% |
-
|
Feb 28
2022 |
PACK
|
William Drew
Chief Financial Officer & EVP |
BUY
Grant, award, or other acquisition
|
Direct | 35,000 Added 8.18% |
-
|
Feb 28
2022 |
PACK
|
Michael Anthony Jones
Director |
BUY
Grant, award, or other acquisition
|
Direct | 105,000 Added 27.58% |
-
|
Feb 28
2022 |
AMRN
|
Steven B Ketchum
Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 16,333 Added 3.15% |
-
|
Feb 28
2022 |
AMRN
|
Steven B Ketchum
Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,508 Reduced 1.1% |
$18,011
$3.27 p/Share
|
Feb 28
2022 |
AMRN
|
Michael Wayne Kalb
SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 16,333 Added 5.98% |
-
|
Feb 28
2022 |
AMRN
|
Michael Wayne Kalb
SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 6,213 Reduced 2.42% |
$20,317
$3.27 p/Share
|
Feb 28
2022 |
AMRN
|
Aaron Berg
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 16,333 Added 4.0% |
-
|
Feb 28
2022 |
DX
|
Jeffrey L Childress
SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 113 Reduced 0.87% |
$1,737
$15.37 p/Share
|
Feb 28
2022 |
EGRX
|
Scott Tarriff |
BUY
Grant, award, or other acquisition
|
Direct | 34,800 Added 2.16% |
-
|
Feb 28
2022 |
EGRX
|
Brian Joseph Cahill
CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 8,000 Added 19.67% |
-
|
Feb 28
2022 |
EGRX
|
Michael Shawn Moran
EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 10,400 Added 24.46% |
-
|
Feb 28
2022 |